| Contrast-Enhanced Ultrasound in Predicting Treatment Response in Patients With Liver Cancer Receiving Transarterial Chemoembolization With Drug Eluting Beads (NCT03045497) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2012-12-12 |
| Utilization of AMSC to Enhance Rotator Cuff Repair - Safety and Efficacy (NCT03838666) | Bioinova, s.r.o. | 2012-12-12 |
| To Evaluate the Influence of the A118G Polymorphism in the mu Opioid Receptor Gene (OPRM1) on Effects of GSK1521498 and Naltrexone on Physiological and Behavioural Markers of Brain Function in Healthy Social Drinkers (NCT01738867) | GlaxoSmithKline | 2012-12-12 |
| An Open-label, Multicenter, Multiple Dose, Phase 1 Study to Establish the Maximum Tolerated Dose of E7389 Liposomal Formulation in Patients With Solid Tumors (NCT01945710) | Eisai Limited | 2012-12-11 |
| M6620 First in Human Study (NCT02157792) | EMD Serono Research & Development Institute, Inc. | 2012-12-10 |
| Phase 1/2 Study of Derazantinib (ARQ 087) in Adult Subjects With Advanced Solid Tumors With FGFR Genetic Alterations (NCT01752920) | Basilea Pharmaceutica | 2012-12-10 |
| Expanded Cord Blood Cell Infusion Following Combination Chemotherapy in Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia (NCT01701323) | Nohla Therapeutics, Inc. | 2012-12-10 |
| Testing the AVI-7100 Flu Drug in Healthy Volunteers (NCT01747148) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-12-08 |
| Infusion of Allogeneic Umbilical Cord Blood-Derived Cluster of Differentiation Antigen 19 (CD19)-Specific T Cells (NCT01362452) | M.D. Anderson Cancer Center | 2012-12-07 |
| A Study to Evaluate the Reactogenicity, Safety, and Immunogenicity of the Third Generation Hepatitis B Vaccine (NCT02692170) | Aribio Lab Co., Ltd. | 2012-12-07 |
| Veliparib and Floxuridine in Treating Patients With Metastatic Epithelial Ovarian, Primary Peritoneal Cavity, or Fallopian Tube Cancer (NCT01749397) | National Cancer Institute (NCI) | 2012-12-07 |
| Tivantinib and Bevacizumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery (NCT01749384) | National Cancer Institute (NCI) | 2012-12-06 |
| Laboratory-Treated T Cells in Treating Patients With High-Risk Relapsed Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia Previously Treated With Donor Stem Cell Transplant (NCT01640301) | Fred Hutchinson Cancer Center | 2012-12-06 |
| Relovair PD PK in Chinese Healthy Subjects (NCT01711463) | GlaxoSmithKline | 2012-12-05 |
| A Study of Oral CFG920 in Patients With Castration Resistant Prostate Cancer (NCT01647789) | Novartis Pharmaceuticals | 2012-12-04 |
| Enoxaparin Bioequivalence Study in Acute Coronary Syndrome Patients (NCT04552067) | University of Monastir | 2012-12-01 |
| Clinical Trial of IV OKN-007 in a Pilot Cohort of Human Recurrent Malignant Glioma Patients (NCT01672463) | Oblato, Inc. | 2012-12-01 |
| A Phase Ib Study of Fruquintinib in 3rd Line mCRC (NCT01975077) | Hutchison Medipharma Limited | 2012-12-01 |
| Dose Escalation Trial of WT1-specific Donor-derived T Cells Following T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed/Refractory Multiple Myeloma (NCT01758328) | Memorial Sloan Kettering Cancer Center | 2012-12-01 |
| Exploring HIV Entry Blockade as a Pre-exposure Prophylaxis Strategy in Women (NCT01749566) | Emory University | 2012-12-01 |
| Safety Study of BMS-986015 (Anti-KIR) in Combination With Ipilimumab in Subjects With Selected Advanced Tumor (NCT01750580) | Bristol-Myers Squibb | 2012-12-01 |
| Clinical Trial of Ambroxol in Patients With Type I Gaucher Disease (NCT01463215) | Exsar Corporation | 2012-12-01 |
| Phase I Study to Assess the Effect on Healthy Male Volunteers of Ketoconazole on the Pharmacokinetics of a Single Dose of AZD5069 Administered Orally. (NCT01735240) | AstraZeneca | 2012-12-01 |
| Possible New Therapy for Advanced Cancer (NCT01832974) | INSYS Therapeutics Inc | 2012-12-01 |
| Study to Assess the Safety, Tolerability and Pharmacokinetics of Fimepinostat (CUDC-907) in Patients With Lymphoma (NCT01742988) | Curis, Inc. | 2012-12-01 |
| Corneal Epithelium Repair and Therapy Using Autologous Limbal Stem Cell Transplantation (NCT02148016) | Sun Yat-sen University | 2012-12-01 |
| Bioequivalence Study of Metformin Hydrochloride Extended-Release Tablets USP 750 mg Under Fasting Condition (NCT01831661) | IPCA Laboratories Ltd. | 2012-12-01 |
| Bioequivalence Study of FLURBIPROFEN 100 mg FAMOTIDINE 20 mg MULTI-LAYER TABLET in Healthy Subjects Under Fasting Conditions (NCT01910090) | Pharmaceutical Research Unit, Jordan | 2012-12-01 |
| Study To Determine The Effect Of Food And Strong CYP3A4 Enzyme Inhibitor On PF-04449913 Drug Levels (NCT01749085) | Pfizer | 2012-12-01 |
| A Phase 1 Dose Escalation Study to Examine the Safety of the P2-VP8 Rotavirus Vaccine (NCT01764256) | PATH | 2012-12-01 |
| Clinical Study of Oral IGF-1R Inhibitor in Subjects With Advanced Refractory Solid Tumors (NCT01779336) | Piramal Enterprises Limited | 2012-12-01 |
| Open Label Pharmacokinetic Study of SAR302503 in Subjects With Hepatic Impairment (NCT01762462) | Bristol-Myers Squibb | 2012-12-01 |
| A Study to Assess the Bioequivalence of a New ULTRACET Extended Release (ER) Tablet With Respect to a Marketed ULTRACET ER Tablet Under Fasted Condition (NCT01778075) | Janssen Korea, Ltd., Korea | 2012-12-01 |
| A Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Food Effect of PMK-S005 After Oral Administration in Healthy Male Volunteers (NCT01762397) | PharmaKing | 2012-12-01 |
| Evaluation of Safety, PK, and Preliminary Effects on Scar Formation of Multiple Intradermal Administrations of RXI-109 (NCT01780077) | RXi Pharmaceuticals, Corp. | 2012-12-01 |
| A Study to Evaluate the Pharmacokinetics of PCI-32765 in Participants With Varying Degrees of Hepatic Impairment (NCT01767948) | Janssen Research & Development, LLC | 2012-12-01 |
| Lenalidomide After Allo Transplant (NCT01750762) | Beth Israel Deaconess Medical Center | 2012-12-01 |
| Safety Study of CC-292 and Rituximab in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (NCT01744626) | Celgene Corporation | 2012-12-01 |
| Safety and Efficacy of Treprostinil in Ischemia and Reperfusion Injury in Adult Orthotopic Liver Transplantation (NCT01481974) | Abhinav Humar, MD | 2012-12-01 |
| Study to See if Platelet Transfusion Stop or Lessen the Effect of the Drug on Platelets (NCT01744288) | AstraZeneca | 2012-12-01 |
| Bioequivalence Study of Etodolac Extended Release Tablets USP 600mg Under Fed Condition (NCT01831687) | IPCA Laboratories Ltd. | 2012-12-01 |
| OTO-201 for Middle Ear Effusion in Pediatric Subjects Requiring Tympanostomy Tube Placement (NCT01755286) | Otonomy, Inc. | 2012-12-01 |
| Treatment of Pulmonary Hypertension Associated COPD With Inhaled Treprostinil-1 (NCT01758744) | University of Colorado, Denver | 2012-12-01 |
| CNDO-109-AANK for AML in First Complete Remission (CR1) (NCT01520558) | Coronado Biosciences, Inc. | 2012-12-01 |
| Pharmacokinetic Interactions Between Telaprevir and Un-boosted Atazanavir (NCT01818856) | Hospitales Universitarios Virgen del Rocío | 2012-12-01 |
| Safety, Tolerability and Immunogenicity Induced by the THV01 Treatment in Patients Infected With HIV-1 Clade B and Treated With Highly Active Antiretroviral Therapy (HAART). (NCT02054286) | Theravectys S.A. | 2012-12-01 |
| High Sodium Diet and External Abdominal Compression in POTS (NCT01771484) | Vanderbilt University | 2012-12-01 |
| A Phase 1 Study of E2022 Tape Formulation for Different Application Sites and Intervals in Japanese Healthy Elderly Males (NCT01843556) | Eisai Co., Ltd. | 2012-12-01 |
| A Multiple Ascending Oral Dose Evaluation of the Safety, Tolerability, and Pharmacokinetics of DSP-1053 and Its Metabolites in Healthy Subjects and in Subjects With Major Depressive Disorder (NCT01774747) | Sumitomo Pharma America, Inc. | 2012-12-01 |
| Study of the Product QGC001 as a Single Dose and Multiple Doses Administered Orally to Healthy Adult Subjects (NCT01900184) | Quantum Genomics SA | 2012-12-01 |
| Evaluation of Safety, Tolerability, and PK of VX15/2503 In Patients With MS (NCT01764737) | Vaccinex Inc. | 2012-12-01 |
| A Single-Dose Study to Assess the Pharmacokinetics of Cabozantinib (XL184) Capsules in Subjects With Impaired Renal Function (NCT01761773) | Exelixis | 2012-12-01 |
| Lenalidomide Plus Bendamustine and Rituximab for Untreated CLL/SLL (NCT01400685) | Massachusetts General Hospital | 2012-12-01 |
| Romidepsin in Combination With Lenalidomide in Adults With Relapsed or Refractory Lymphomas and Myeloma (NCT01755975) | Memorial Sloan Kettering Cancer Center | 2012-12-01 |
| Bioequivalence Study of Metformin Hydrochloride Extended-Release Tablets USP 750 mg Under Fed Condition (NCT01831674) | IPCA Laboratories Ltd. | 2012-12-01 |
| A Study of LY3053102 in Healthy Participants (NCT01736241) | Eli Lilly and Company | 2012-12-01 |
| Pharmacokinetic Study of CXB909 in Healthy Male Subjects (NCT01505907) | CeNeRx BioPharma Inc. | 2012-12-01 |
| The Boceprevir and Sildenafil Pharmacokinetics Study (NCT01499498) | Imperial College London | 2012-12-01 |
| Clinical Trial to Evaluate Bone Marrow Stem Cell Therapy for PSP, a Rare Form of Parkinsonism (NCT01824121) | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 2012-12-01 |
| A Study of LY2922470 in Healthy Participants and Participants With Diabetes (NCT01746017) | Eli Lilly and Company | 2012-12-01 |
| A Study of KX2-391 With Paclitaxel in Patients With Solid Tumors (NCT01764087) | Hanmi Pharmaceutical Company Limited | 2012-12-01 |
| Assessing the Effect of Met DR on Plasma Glucose and PK in Subjects With T2DM (NCT01804842) | Elcelyx Therapeutics, Inc. | 2012-12-01 |
| Study to Assess the Safety and Tolerability of Single Doses of REGN1500 (NCT01749878) | Regeneron Pharmaceuticals | 2012-12-01 |
| Single and Multiple Dose Study in Japanese (NCT01744379) | Ardea Biosciences, Inc. | 2012-12-01 |
| A Dose Escalation Study of Intranasal Neuropeptide Y in Post Traumatic Stress Disorder (PTSD) (NCT01533519) | James Murrough | 2012-12-01 |
| A Phase I/II Study Afatinib/Carboplatin/Paclitaxel Induction Chemotherapy In HPV-Negative HNSCC. (NCT01732640) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2012-12-01 |
| Antalgic Treatment of Painful Bone Metastases by US-guided High Intensity Focused Ultrasound (HIFU) (NCT01765907) | Theraclion | 2012-12-01 |
| Bacteriotherapy in Pediatric Inflammatory Bowel Disease (NCT01757964) | David Suskind | 2012-12-01 |
| Russian Clinical Trial of Mesenchymal Cells in Patients With Septic Shock and Severe Neutropenia (NCT01849237) | National Research Center for Hematology, Russia | 2012-12-01 |
| Study to Assess Pegloticase (KRYSTEXXA®) in Patients on Hemodialysis (NCT01739660) | Savient Pharmaceuticals | 2012-12-01 |
| Vasopressors for Cerebral Oxygenation (NCT02009007) | Samsung Medical Center | 2012-12-01 |
| Pharmacokinetic Characterization of the Active, Separated System With PK Controller (Fentanyl Iontophoretic Transdermal System, 40 Mcg Fentanyl Per Activation). (NCT01750060) | Incline Therapeutics, Inc. | 2012-12-01 |
| Safety and Pharmacokinetics Between Fixed-dose Combination VR 160/20 mg and Co-administration of Diovan® (Valsartan) Film-coated Tablet 160 mg and Crestor® (Rosuvastatin) 20 mg (NCT01918358) | LG Life Sciences | 2012-12-01 |
| A Phase 1/2 Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma (NCT01796171) | Nordic Nanovector | 2012-12-01 |
| A Study of the Effect of ONO-8539 on Oesophageal Pain Hypersensitivity in Patients With Non-erosive Reflux Disease (NCT01707901) | Ono Pharmaceutical Co., Ltd. | 2012-12-01 |
| Study of the Combination of BKM120 and Cisplatin or Carboplatin in Patients With Advanced Solid Tumors (NCT02439489) | Fondazione Michelangelo | 2012-12-01 |
| Phase Ib/II Study of the Efficacy and Safety of the R-CMC544/R-GEMOX Combination in Diffuse Lage B-cell Lymphoma at First or Second Relapse (NCT01562990) | The Lymphoma Academic Research Organisation | 2012-12-01 |
| Safety Study of Endobronchial Transplantation of Autologous Mesenchymal Stem Cells (MSCs) in Emphysema Patients (NCT01758055) | Arda Kiani | 2012-12-01 |
| A Study To Assess The Safety And Tolerability Of Different Doses Of PF-06444753 And PF-06444752 In Subjects With Allergic Rhinitis (NCT01723254) | Pfizer | 2012-12-01 |
| Phase I/II Trial of AXL1717 in the Treatment of Recurrent Malignant Astrocytomas (NCT01721577) | Rush University Medical Center | 2012-12-01 |
| A Single Dose Study to Assess the Safety, Effects, and Blood and Urine Drug Levels of AZD3293 in Healthy Subjects (NCT01739647) | AstraZeneca | 2012-12-01 |
| Investigation of the Pharmacokinetics of Turoctocog Alfa in Subjects With Haemophilia A (NCT01692925) | Novo Nordisk A/S | 2012-12-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HS-20004 in Healthy Chinese Volunteers (NCT02746302) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2012-12-01 |
| PI3K Inhibitor BYL719 in Combination With the HSP90 Inhibitor AUY922 in Patients With Advanced or Metastatic Gastric Cancer (NCT01613950) | Novartis Pharmaceuticals | 2012-12-01 |
| Phase 1 Trial With SIR-Spheres and Cetuximab +/- Erlotinib (NCT01432119) | M.D. Anderson Cancer Center | 2012-12-01 |
| The Role of Melatonin in the Regulation of Blood Coagulation (NCT01741389) | University of Oslo | 2012-12-01 |
| A Randomised, Single Centre, Double-blind, Two-period, Cross-over Trial in Healthy Subjects Investigating the Bioequivalence Between Subcutaneous Injections of Semaglutide Produced by Two Manufacturing Processes (NCT01766245) | Novo Nordisk A/S | 2012-12-01 |
| Viral Kinetics in HCV Clearance in Subjects With Hemophilia (NCT01704521) | Kenneth Sherman | 2012-12-01 |
| A Study of LY2922083 in Healthy Participants and Participants With Diabetes (NCT01748552) | Eli Lilly and Company | 2012-12-01 |
| Radiotherapy Plus Hormone Therapy in Biochemically-relapsing Prostate Cancer Patients Following Surgery (NCT01780220) | UNICANCER | 2012-12-01 |
| Quantitative 18F-AV-133 PET Imaging in Subjects With Diabetes and Healthy Controls (NCT01710371) | Avid Radiopharmaceuticals | 2012-12-01 |
| Study of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy (NCT02527746) | EVIVE Biotechnology | 2012-12-01 |
| A Study of Evacetrapib in Healthy Participants (NCT01736254) | Eli Lilly and Company | 2012-12-01 |
| Effects of Niacin On Fatty Acid Trapping (NCT01984073) | University of Pennsylvania | 2012-12-01 |
| Pharmacokinetic, Bioavailability, and Safety Study of COV155 Administered in Healthy Subjects Under Fed and Fasted Conditions (NCT02561741) | Mallinckrodt | 2012-12-01 |
| Long-term PK and Safety/Tolerability Testing LDLL600 Against Esmolol in Healthy Volunteers (NCT01741519) | AOP Orphan Pharmaceuticals AG | 2012-12-01 |
| Culturally Sensitive Intervention to Improve Retention in HIV Care for Latino MSM (NCT01457066) | University of California, Los Angeles | 2012-12-01 |
| DDI Potential: Dapivirine Vaginal Ring and Miconazole Nitrate (NCT01731574) | International Partnership for Microbicides, Inc. | 2012-12-01 |
| Mesenchymal Stem Cells for Progressive Multiple Sclerosis_Sweden (NCT03778333) | Karolinska Institutet | 2012-12-01 |
| Effects of Intravenous Bendavia™ on Reperfusion Injury in Patients Undergoing Angioplasty of the Renal Artery (NCT01755858) | Stealth BioTherapeutics Inc. | 2012-12-01 |